QIAGEN N.V. (QGEN:NYSE)
$45.16 -0.22 (-0.4848%)
Analysed QIAGEN N.V. (QGEN:NYSE) News Sources
QIAGEN (QGEN) Rolls Out QIAsymphony Connect Following Q2 Outperformance
17-09-2026
yahoo.com
Qiagen Shares Rise 4% Following Report of Private Equity Takeover Interest
17-09-2026
advfn.com
Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen
18-09-2026
yahoo.com
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
18-09-2026
yahoo.com
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board
18-09-2026
yahoo.com
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation
24-09-2026
yahoo.com
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
28-09-2026
yahoo.com
Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen
01-10-2026
yahoo.com
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
02-10-2026
yahoo.com
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
06-10-2026
yahoo.com
What is the current price of QIAGEN N.V. (QGEN:NYSE)?
The current price of QIAGEN N.V. (QGEN:NYSE) is $45.16.
QIAGEN N.V. (QGEN:NYSE) absolute price change since previous trading day?
The absolute price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is $-0.22.
QIAGEN N.V. (QGEN:NYSE) percentage price change since previous trading day?
The percentage price change of QIAGEN N.V. (QGEN:NYSE) since the previous trading day is -0.4848%.
What is the most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE)?
The most recent average sentiment score for QIAGEN N.V. (QGEN:NYSE) is 83 out of 100.
What is the most recent average sentiment for QIAGEN N.V. (QGEN:NYSE)?
The most recent sentiment for QIAGEN N.V. (QGEN:NYSE) is .
SEC-8K** Filing Available For QIAGEN N.V. (QGEN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.